Commentary regarding double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams-Huet, da Khan. J Allergy Clin Immunol Pract 2:601-606, 2014

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)102-103
Number of pages2
JournalDermatologic Therapy
Issue number2
StatePublished - Mar 1 2015


  • dapsone
  • therapy
  • urticaria

ASJC Scopus subject areas

  • Dermatology

Cite this